MAPT and Alzheimer disease: Leveraging 1,370 tau PET scan visits from 832 ADNI participants across the Alzheimer’s disease spectrum, we characterized the spatial extent of tau pathology across the whole brain (70 brain regions) both cross-sectionally and longitudinally.